Sustainability | October 14, 2022
JB Pharma publishes its maiden sustainability report
Since FY 2020 till FY 2022, the organisation has reduced energy consumption by 9.2%
Since FY 2020 till FY 2022, the organisation has reduced energy consumption by 9.2%
The Bulk Drug Park is expected to attract investment of around Rs. 10,000 crore and provide employment to more than 20,000 people
68% of children on a higher dose of Dupixent achieved histological disease remission at week 16
The Coalition for Epidemic Preparedness Innovations (CEPI) has recently partnered with the consortium of India-based Bharat Biotech, University of Sydney and ExcellGene to develop “variantproof” COVID-19 vaccine.
Cumulatively, almost 75% of the health centres in the country have been electrified with a cumulative solar capacity of 3.5 MW
The reduction in force will result in financial savings of approximately $50 million annually beginning in 2023
DSCO has requested WHO to share at the earliest with CDSCO the report on establishment of causal relation to death with the medical products in question etc.
Brivaracetam is indicated for the treatment of partial-onset seizures in patients 4 years of age and older.
The product will be manufactured at Lupin's facility in Nagpur, India.
Amantadine Extended-Release capsules had annual sales of US $2.7 million in the United States according to IQVIA data
Subscribe To Our Newsletter & Stay Updated
